Last reviewed · How we verify
NCT05552989
Towards Better Preparedness for Future Catastrophes - Local Lessons-learned From COVID-19
trial testing this is a non-interventional study in COVID-19 Pandemic in 12 participants. Completed in 21 June 2023.
12 April 2023
Quick facts
| Lead sponsor | University Hospital Heidelberg |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 12 |
| Start date | 23 September 2022 |
| Primary completion | 12 April 2023 |
| Estimated completion | 21 June 2023 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- this is a non-interventional study
Conditions studied
- COVID-19 Pandemic — all drugs for COVID-19 Pandemic →
- Emergencies — all drugs for Emergencies →
Sponsor
University Hospital Heidelberg
Who can join
18 and older, any sex, with COVID-19 Pandemic or Emergencies. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The research question of this study is: "what lessons have been learned from the civil-military cooperation in Heidelberg, Germany, during the COVID-19 pandemic, and what needs to be done to be better prepared for future disasters?" It is expected that the results of this research provide a deep expert insight into COVID-19 disaster preparedness at the local level. Flanked by comparison with published experiences at the global level, these lessons-learned would contribute to strengthening local crisis resilience sustainably in the future.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05552989
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19 Pandemic
Currently open trials in the same condition.
- NCT05825651 — Long COVID and Its Associations With Health Outcomes in Older Adults · active not recruiting
- NCT06927622 — Corona Virus Disease 2019 Cohort Study · recruiting
- NCT05096260 — Getting to Yes, Michigan! (G2YMI) · NA · active not recruiting
- NCT06208943 — Neural and Cognitive Consequences of COVID-19 Survival · recruiting
Other University Hospital Heidelberg trials
Trials by the same sponsor.
- NCT07388147 — Exercise Therapy for Multiple Myeloma Patients · NA · not yet recruiting
- NCT07348874 — Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany · not yet recruiting
- NCT07181928 — Is Mentalization-based Therapy More Effective Than Treatment-as-usual for Adolescents With Dissocial Disorders? · NA · not yet recruiting
- NCT06954623 — Partial Breast Re-irradiation for Breast Cancer · NA · recruiting
- NCT06913010 — DV 100 as a Framework for the Hospital Incident Command System · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05552989 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Heidelberg
- Last refreshed: 29 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05552989.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing